This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200304-578OCv1 170/4/395    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hopkinson, N. S. Articles by Polkey, M. I. Search for Related Content PubMed PubMed Citation Articles by Hopkinson, N. S. Articles by Polkey, M. I.

Angiotensin Converting Enzyme Genotype and Strength in Chronic Obstructive Pulmonary Disease

Respiratory Muscle Laboratory, Royal Brompton Hospital; Department of Cardiovascular Genetics, Rayne Institute; and Respiratory Muscle Laboratory, Guy's King's and St Thomas' School of Medicine, King's College Hospital, London, United Kingdom

Correspondence and requests for reprints should be addressed to Nicholas Hopkinson, M.A., M.R.C.P., Respiratory Muscle Laboratory, Royal Brompton Hospital, Fulham Road, London, SW3 6NP, United Kingdom. E-mail: n.hopkinson{at}ic.ac.uk

Quadriceps muscle weakness is an important contributor to exercise limitation in patients with chronic obstructive pulmonary disease. The deletion allele of the angiotensin converting enzyme gene polymorphism has previously been associated with a greater response to strength training in healthy subjects and might, therefore, protect against detraining in these patients. In 103 stable outpatients (mean [SD] FEV₁ 34.4 [16.5] % predicted), the angiotensin deletion allele was associated with greater isometric quadriceps strength; mean (SD) 31.4 (10.8) kg for insertion homozygotes, 34.1 (13.0) kg for heterozygotes, and 38.3 (11.6) kg for deletion homozygotes (p = 0.04 linear trend). Adjusted for fat-free mass, the relationship was stronger (linear trend p = 0.007). There was no correlation between strength and genotype in a group of 101 age-matched healthy control subjects. Twitch quadriceps force in response to magnetic femoral nerve stimulation, measured in 39 patients, was also genotype dependent; 8.3 (2.6) kg for insertion homozygotes, 10.1 (3.6) kg for heterozygotes, and 12.4 (3.5) kg for deletion homozygotes (p = 0.002 linear trend). Body mass index and fat-free mass did not differ significantly between genotypes in either group. There was no association in either patients or control subjects between genotype and inspiratory muscle strength. In chronic obstructive pulmonary disease the deletion allele is associated with greater quadriceps strength independent of confounding factors.

Key Words: gene polymorphism • respiratory muscle • skeletal muscle

This article has been cited by other articles:

				P. J. Barnes and B. R. Celli Systemic manifestations and comorbidities of COPD Eur. Respir. J., May 1, 2009; 33(5): 1165 - 1185. [Abstract] [Full Text] [PDF]

				A. Vigano, B. Trutschnigg, R. D. Kilgour, N. Hamel, L. Hornby, E. Lucar, W. Foulkes, M. L. Tremblay, and J. A. Morais Relationship Between Angiotensin-Converting Enzyme Gene Polymorphism and Body Composition, Functional Performance, and Blood Biomarkers in Advanced Cancer Patients Clin. Cancer Res., April 1, 2009; 15(7): 2442 - 2447. [Abstract] [Full Text] [PDF]

				T. McCauley, S. S. Mastana, J. Hossack, M. MacDonald, and J. P. Folland Human angiotensin-converting enzyme I/D and {alpha}-actinin 3 R577X genotypes and muscle functional and contractile properties Exp Physiol, January 1, 2009; 94(1): 81 - 89. [Abstract] [Full Text] [PDF]

				P. J. Barnes Future Treatments for Chronic Obstructive Pulmonary Disease and Its Comorbidities Proceedings of the ATS, December 1, 2008; 5(8): 857 - 864. [Abstract] [Full Text] [PDF]

				P. D. Wagner Possible mechanisms underlying the development of cachexia in COPD Eur. Respir. J., March 1, 2008; 31(3): 492 - 501. [Abstract] [Full Text] [PDF]

				N. S Hopkinson, K. W. Li, A. Kehoe, S. E Humphries, M. Roughton, J. Moxham, H. Montgomery, and M. I Polkey Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease Am. J. Clinical Nutrition, February 1, 2008; 87(2): 385 - 390. [Abstract] [Full Text] [PDF]

				E Barreiro, A M W J Schols, M I Polkey, J B Galdiz, H R Gosker, E B Swallow, C Coronell, J Gea, and on behalf of the ENIGMA in COPD project Cytokine profile in quadriceps muscles of patients with severe COPD Thorax, February 1, 2008; 63(2): 100 - 107. [Abstract] [Full Text] [PDF]

				E. B Swallow, D. Reyes, N. S Hopkinson, W. D-C Man, R. Porcher, E. J Cetti, A. J Moore, J. Moxham, and M. I Polkey Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease Thorax, February 1, 2007; 62(2): 115 - 120. [Abstract] [Full Text] [PDF]

				M. Meysman Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial. Eur. Respir. J., September 1, 2006; 28(3): 670 - 670. [Full Text] [PDF]

				S. Andreas From the authors Eur. Respir. J., September 1, 2006; 28(3): 670 - 671. [Full Text] [PDF]

				S. Andreas, C. Herrmann-Lingen, T. Raupach, L. Luthje, J. A. Fabricius, N. Hruska, W. Korber, B. Buchner, C-P. Criee, G. Hasenfuss, et al. Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial Eur. Respir. J., May 1, 2006; 27(5): 972 - 979. [Abstract] [Full Text] [PDF]

				N. S Hopkinson, K. I Eleftheriou, J. Payne, A. H Nickol, E. Hawe, J. Moxham, H. Montgomery, and M. I Polkey +9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease. Am. J. Clinical Nutrition, April 1, 2006; 83(4): 912 - 917. [Abstract] [Full Text] [PDF]

				M. A. Spruit, R. Gosselink, T. Troosters, A. Kasran, M. Van Vliet, and M. Decramer Low-Grade Systemic Inflammation and the Response to Exercise Training in Patients With Advanced COPD Chest, November 1, 2005; 128(5): 3183 - 3190. [Abstract] [Full Text] [PDF]

				M. Van Vliet, M. A. Spruit, G. Verleden, A. Kasran, E. Van Herck, F. Pitta, R. Bouillon, and M. Decramer Hypogonadism, Quadriceps Weakness, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1105 - 1111. [Abstract] [Full Text] [PDF]

				W D-C Man, N S Hopkinson, F Harraf, D Nikoletou, M I Polkey, and J Moxham Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease Thorax, September 1, 2005; 60(9): 718 - 722. [Abstract] [Full Text] [PDF]

				T. Troosters, R. Casaburi, R. Gosselink, and M. Decramer Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 19 - 38. [Full Text] [PDF]

				L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004 Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 686 - 698. [Full Text] [PDF]

				H. R. Gosker, H.-J. Pennings, and A. M. W. J. Schols ACE Gene Polymorphism in COPD Am. J. Respir. Crit. Care Med., September 1, 2004; 170(5): 572 - 572. [Full Text] [PDF]

				N. S. Hopkinson, A. H. Nickol, J. Payne, E. Hawe, W. D.-C. Man, J. Moxham, H. Montgomery, and M. I. Polkey ACE Gene Polymorphism in COPD Am. J. Respir. Crit. Care Med., September 1, 2004; 170(5): 572 - 573. [Full Text]